Safety, Tolerability, and Immunogenicity of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine: A Randomised, Double-Blind, Placebo-Controlled, Phase 1-2 Clinical Trial (ABDALA Study)-Reference-Cited by-同舟云学术

Safety, Tolerability, and Immunogenicity of a SARS-CoV-2 Recombinant Spike RBD Protein Vaccine: A Randomised, Double-Blind, Placebo-Controlled, Phase 1-2 Clinical Trial (ABDALA Study)

Published:2022 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Hernández-Bernal Francisco,Ricardo-Cobas Maria del Carmen,Martín-Bauta Yenima,Navarro-Rodríguez Zadis,Piñera-Martínez Marjoris,Quintana-Guerra Joel,Urrutia-Pérez Karen,Urrutia-Pérez Klaudia,Chávez-Chong Cristina Olimpia,Azor Hernández Jorge Luis,Rodríguez-Reinoso José Luis,Lobaina-Lambert Leonardo,Colina-Ávila Elizabeth,Bizet-Almeida Jacqueline,Rodríguez-Nuviola Jeniffer,del Valle-Piñera Sergio,Ramírez-Domínguez Mayara,Tablada-Ferreiro Elisangela,Valdés Marel A.,Lemos-Pérez Gilda,Guillén-Nieto Gerardo E.,Palenzuela-Diaz Ariel,Noa-Romero Enrique,Limonta-Fernández Miladys,Fernández-Ávila Juan M.,Ali-Mros Nabil A.,del Toro-Lahera Lianne,Remedios-Reyes Rossana,Ayala-Ávila Marta,Muzio-González Verena L.

Publisher

Elsevier BV

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference33 articles.

1. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China;N Zhu;N Engl J Med,2019

2. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19);D G Ahn;J Microbiol Biotechnol,2020

3. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak;H A Rothan;J Autoimmun,2020

4. Accelerating Development of SARS-CoV-2 Vaccines -The Role for Controlled Human Infection Models;M E Deming;N Engl J Med,2020